ADMA BIOLOGICS, INC. Payments to Acquire Short-term Investments
ADMA BIOLOGICS, INC. (ADMA) reported Payments to Acquire Short-term Investments of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-29.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireShortTermInvestments · last filed 2018-03-29
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for the quarter ending 2017-09-30 was $0.00.
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for the quarter ending 2016-12-31 was $11.02M, a 0.03% increase year-over-year.
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for the quarter ending 2016-09-30 was -$244.27K.
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for fiscal 2016 was $15.68M, a 13.51% decline from fiscal 2015.
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for fiscal 2015 was $18.13M, a 955.61% increase from fiscal 2014.
- ADMA BIOLOGICS, INC. payments to acquire short-term investments for fiscal 2014 was $1.72M, a 41.49% decline from fiscal 2013.
| Period end | Payments to Acquire Short-term Investments 3 month | Payments to Acquire Short-term Investments 6 month | Payments to Acquire Short-term Investments 9 month | Payments to Acquire Short-term Investments 12 month | Payments to Acquire Short-term Investments 12 month as first filed |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $0.00 derived: sum of 2 quarters · filed 2018-03-29 | $0.00 10-K · filed 2018-03-29 | ||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $0.00 10-Q · filed 2017-11-03 | |||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | ||||
| 2016-12-31 | $11.02M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $10.78M derived: sum of 2 quarters · filed 2018-03-29 | $15.68M 10-K · filed 2018-03-29 | ||
| 2016-09-30 | -$244.27K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $4.66M 10-Q · filed 2017-11-03 | |||
| 2016-06-30 | $4.90M 10-Q · filed 2017-08-11 | ||||
| 2015-12-31 | $11.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $6.85M derived: sum of 2 quarters · filed 2017-02-24 | $11.27M derived: sum of 3 quarters · filed 2017-02-24 | $18.13M 10-K · filed 2017-02-24 | $1.72M 10-K · filed 2016-03-23 |
| 2015-09-30 | -$4.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $252.15K derived: sum of 2 quarters · filed 2016-11-10 | $7.11M 10-Q · filed 2016-11-10 | $5.44M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $4.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | $11.28M 10-Q · filed 2016-08-12 | $9.61M derived: sum of 3 quarters · filed 2016-08-12 | $9.62M derived: sum of 4 quarters · filed 2016-08-12 | |
| 2015-03-31 | $6.86M 10-Q · filed 2015-05-12 | $5.19M derived: sum of 2 quarters · filed 2016-03-23 | $5.20M derived: sum of 3 quarters · filed 2016-03-23 | $8.58M derived: sum of 4 quarters · filed 2016-03-23 | |
| 2014-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | -$1.66M derived: sum of 2 quarters · filed 2016-03-23 | $1.72M derived: sum of 3 quarters · filed 2016-03-23 | $1.72M 10-K · filed 2016-03-23 | |
| 2014-09-30 | $6.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | $3.38M derived: sum of 2 quarters · filed 2015-11-10 | $3.38M 10-Q · filed 2015-11-10 | ||
| 2014-06-30 | $3.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $3.38M 10-Q · filed 2015-08-11 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-12 | ||||
| 2013-12-31 | $2.94M 10-K · filed 2015-03-09 | ||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |